Today: 24 April 2026
Intel Stock Eyes a Record as AI Data Centers Put CPUs Back in Play

Intel Stock Eyes a Record as AI Data Centers Put CPUs Back in Play

SANTA CLARA, California, April 24, 2026, 04:05 PDT

  • Intel is looking for second-quarter revenue to land between $13.8 billion and $14.8 billion, a range that tops analyst forecasts, after posting stronger-than-expected first-quarter sales.
  • Intel shares surged 28% to $85 before the bell, setting the stock up for a record-breaking open.
  • Tesla is set to tap Intel’s 14A process, handing Intel Foundry its first marquee external client for the tech. Still, specifics around the project are scarce.

Intel shares looked poised for a record open Friday. The chipmaker had issued a forecast that beat expectations, pointing to stronger demand for its server processors as companies ramp up spending on artificial intelligence systems.

This shift is significant for Intel, which largely sat out the initial AI chip surge fueled by GPUs, the key hardware for training AI models. Now, as the focus turns to inference—the process where AI responds to user prompts—there’s fresh momentum for CPUs, the core chips powering servers and managing tasks.

Intel turned in $13.6 billion in revenue for the first quarter, a 7% bump year over year. The company disclosed a GAAP net loss of $3.7 billion, or 73 cents per share. Stripping out certain items, adjusted earnings landed at 29 cents per share, a non-GAAP figure.

The company is forecasting second-quarter revenue between $13.8 billion and $14.8 billion, and it’s guiding to adjusted earnings of 20 cents per share. That’s ahead of what analysts were looking for: LSEG data via Reuters showed revenue expectations at $13.07 billion and earnings at just 9 cents a share.

Intel CFO David Zinsner pointed to “unprecedented demand for silicon” this quarter, adding that supply execution improved. CEO Lip-Bu Tan echoed the supply-demand imbalance, noting Xeon server CPUs in particular are selling faster than the company can deliver. Intel Corporation

Intel’s data center and AI segment turned in $5.1 billion in revenue, climbing 22% over last year. The company’s client computing group—its core PC chips—generated $7.7 billion, barely edging up 1%. Intel Foundry posted $5.4 billion, marking a 16% gain.

Tan told analysts the CPU is “reasserting itself” in AI setups, while Xeon server demand is showing real momentum. He pointed out that customers are shifting back to deploying more server CPUs relative to accelerators, with the ratio tilting toward CPUs—despite GPUs still holding the key role in frontier AI. download.intel.com

There was a catch to the rebound. Intel CFO David Zinsner pointed out they’d managed to offload some finished-goods inventory, parts they didn’t expect to shift—mostly older or less advanced chips. “I am not sure we have that benefit in the second quarter,” he added. Reuters

The foundry angle picked up momentum after Tesla CEO Elon Musk said the company intends to tap Intel’s upcoming 14A process for its Terafab AI chip project in Austin, Texas. That’s a notable win for Intel as it pushes to challenge TSMC’s dominance in contract chipmaking. Still, Seaport Research Partners analyst Jay Goldberg cautioned that while the Tesla agreement isn’t on the same volume scale as Apple or Nvidia, “It can be real volumes.” Reuters

Intel Foundry’s expenses continue to weigh. Zinsner put external foundry revenue at $174 million for the quarter, but the segment posted an operating loss of $2.4 billion—driven in part by early-phase spending on Intel 18A and increased outlays on 14A as customers ran evaluations.

Here’s the catch: Intel has to keep its fabs humming, manage supply, and keep up demand, even as PC sales show signs of slipping. The company expects PC unit demand to drop by a low double-digit percentage in the second half, and flagged rising costs—memory, wafers, substrates—that could drag on demand further down the line.

Investors aren’t hesitating to pay a premium. Intel shares climbed roughly 80% this year before Friday’s anticipated surge, Reuters noted, with the stock changing hands at nearly 90 times 12-month forward earnings—higher than both AMD and Nvidia. So, the margin for error is thin if Intel misses its next ramp.

Stock Market Today

  • Inflation Underestimation Could Benefit Financial Markets
    April 24, 2026, 9:15 AM EDT. Recent analysis suggests inflation is underestimated by standard measures, raising concerns about the economy. Yet, this unexpected persistence might act as a tailwind for financial markets, supporting asset prices. Markets often respond positively to moderate inflation, which can signal stronger demand and economic activity. Investors weighing inflation risks should consider its nuanced impact on sectors and investment strategies moving forward.

Latest article

Expedia Group CFO Shake-Up Sends EXPE Stock Sliding Before Earnings

Expedia Group CFO Shake-Up Sends EXPE Stock Sliding Before Earnings

24 April 2026
Expedia Group appointed former Snap CFO Derek Andersen as chief financial officer, effective May 11. Outgoing CFO Scott Schenkel will leave May 16 after the May 7 earnings call. Expedia shares dropped 5.4% Thursday, trailing other online travel stocks. The company said Schenkel’s exit was not due to any disagreement over operations or accounting.
Amazon-Backed X-Energy’s $1 Billion IPO Puts Nuclear Power Back in the AI Spotlight

Amazon-Backed X-Energy’s $1 Billion IPO Puts Nuclear Power Back in the AI Spotlight

24 April 2026
X-energy raised about $1.02 billion in an upsized IPO, pricing 44.25 million shares at $23 each, 21% above the marketed range. Trading under “XE” on Nasdaq was set to begin Friday. The company has not yet delivered a commercial Xe-100 reactor or reached final investment decisions. Amazon anchored a prior $500 million financing round for X-energy.
Regeneron Stock Is Back In Focus: Why Wall Street Sees More Upside After Trump Deal

Regeneron Stock Is Back In Focus: Why Wall Street Sees More Upside After Trump Deal

24 April 2026
Regeneron shares rose 2.6% Thursday after the company announced a U.S. drug-pricing agreement and said it would offer its new Otarmeni gene therapy free in the U.S. The stock closed at $766.02, up for the week and month but down 1.3% year to date. Raymond James and Cantor Fitzgerald reiterated bullish ratings and high price targets ahead of first-quarter results due April 29.
Wren Kitchens Abrupt U.S. Shutdown: Showrooms Close, Layoffs Hit Pennsylvania
Previous Story

Wren Kitchens Abrupt U.S. Shutdown: Showrooms Close, Layoffs Hit Pennsylvania

AMD Stock Jumps as Intel’s AI CPU Boom Puts $500 Billion in Sight
Next Story

AMD Stock Jumps as Intel’s AI CPU Boom Puts $500 Billion in Sight

Go toTop